Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel.

MLA

Guedalia, Joshua, et al. “Effectiveness of a Third BNT162b2 MRNA COVID-19 Vaccination during Pregnancy: A National Observational Study in Israel.” Nature Communications, vol. 13, no. 1, Nov. 2022, p. 6961. EBSCOhost, https://doi.org/10.1038/s41467-022-34605-x.

APA

Guedalia, J., Lipschuetz, M., Calderon-Margalit, R., Cohen, S. M., Goldman-Wohl, D., Kaminer, T., Melul, E., Shefer, G., Sompolinsky, Y., Walfisch, A., Yagel, S., & Beharier, O. (2022). Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel. Nature Communications, 13(1), 6961. https://doi.org/10.1038/s41467-022-34605-x

Chicago

Guedalia, Joshua, Michal Lipschuetz, Ronit Calderon-Margalit, Sarah M Cohen, Debra Goldman-Wohl, Tali Kaminer, Eli Melul, et al. 2022. “Effectiveness of a Third BNT162b2 MRNA COVID-19 Vaccination during Pregnancy: A National Observational Study in Israel.” Nature Communications 13 (1): 6961. doi:10.1038/s41467-022-34605-x.